06 February 2024, Baden-Württemberg, Mannheim: Claudia Fleischer, Managing Director of Roche Diagnostics GmbH, stands on a staircase at Roche Pharma's annual press conference. The business results for ...

If you are wondering whether Roche Holding is still an attractive opportunity after its recent run, or whether that value is already reflected in the price, this article will walk through what the ...

The stock price of Roche (OTCMKTS: RHHBY) is up 10% in a week, compared to around a 10% fall for its peer Eli Lilly stock (NYSE: LLY) over this period. The rise in Roche stock in recent days can ...

Tuesday, Roche Holding AG (OTC:RHHVF) (ROG:SW) (OTC: RHHBY (OTC:RHHBY)), a pharmaceutical giant with a market capitalization of $265.76 billion, saw its price target increased by Deutsche Bank ...

On Thursday, UBS analyst Matthew Weston upgraded Roche Holding (OTC:RHHBY) stock from Neutral to Buy, adjusting the price target to CHF 338.00, up from the previous CHF 300.00. The upgrade comes as ...

Roche reported positive Phase III results on trials of its new multiple sclerosis (MS) drug today. Fenebrutinib appears effective at treating both relapsing multiple sclerosis and primary progressive ...

This morning, Roche announced results of its new GLP-1 drug trial showing patients losing an average of 7.3% of their body weight after four weeks of treatment, which it calls a "clinically meaningful ...

Roche Holding AG stock has seen a 13% price rise in the past month following positive trial results for its obesity treatment. Weight management and associated diseases like diabetes have huge ...

Roche Holding AG's acquisition of Poseida for $1.5bn is a smart move by Big Pharma as allogeneic cell therapies are becoming increasingly de-risked. Despite recent challenges, Roche's diverse ...

Roche just reported some solid data with its weight loss pill program. Competitors might have a problem on the horizon as a result. But a lot needs to happen between today and that program's debut.

06 February 2024, Baden-Württemberg, Mannheim: Daniela Kahlert, Managing Director of Roche Diagnostics Deutschland GmbH, stands on a staircase at Roche Pharma's annual press conference. The business ...

The stock price of Roche (OTCMKTS: RHHBY) trades at $35 per share, about 33% below its peak level of over $53 seen in April 2022. In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% ...